Pacira BioSciences, Inc. PCRX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s accumulated depreciation?
- Pacira BioSciences, Inc. (PCRX) reported accumulated depreciation of $144.71M in Q1 2026.
- How has Pacira BioSciences, Inc.'s accumulated depreciation changed year-over-year?
- Pacira BioSciences, Inc.'s accumulated depreciation increased by 3.5% year-over-year, from $139.78M to $144.71M.
- What is the long-term trend for Pacira BioSciences, Inc.'s accumulated depreciation?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s accumulated depreciation has grown at a 11.9% compound annual growth rate (CAGR), from $78.36M to $137.7M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.